Table 1.
Clinical Characteristics of Study Sample (Mean±SD, Median (IQR) or percent) by progestin type
| Estranes/gonanes (N=16) |
Drospirenone (N= 7) |
|
|---|---|---|
| Age (years) | 24.9±2.9 | 23.9±1.7 |
| Body mass index (kg/m2) | 21.9±2.7 | 23.3±4.2 |
| Systolic blood pressure (mm Hg) | 106.8±11.3 | 112.6±5.5 |
| Diastolic blood pressure (mm Hg) | 67±9.9 | 68.9±6.6 |
| Heart rate (min−1) | 67.2±10.7 | 77.6±6.7 |
| Hemoglobin (g/dL) | 12.8±0.8 | 12.9±0.8 |
| % Hemoglobin <12g/dl | 18.75% | 16.67% |
| Duration of lifetime OCP use (months) | 47 (40–67) | 34 (12–58) |
| Duration of most recent type of OCP use (months) | 32 (10–57) | 10 (6–34) |
| Estrogen dose (%) | ||
| Low dose (20–25 mcg) | 68.8% | 71.4% |
| High dose (>25 mcg) | 31.2% | 28.6% |